AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $317,000 | -43.4% | 39,273 | -31.3% | 0.04% | -29.8% |
| Q3 2021 | $560,000 | +57.3% | 57,148 | +8.0% | 0.06% | +42.5% |
| Q2 2021 | $356,000 | +215.0% | 52,933 | +136.4% | 0.04% | +110.5% |
| Q3 2020 | $113,000 | -4.2% | 22,390 | +53.3% | 0.02% | -71.2% |
| Q2 2020 | $118,000 | -42.4% | 14,610 | -68.6% | 0.07% | +500.0% |
| Q3 2018 | $205,000 | -85.8% | 46,597 | -80.2% | 0.01% | -84.7% |
| Q2 2018 | $1,442,000 | -37.4% | 235,217 | -25.6% | 0.07% | -41.0% |
| Q1 2018 | $2,303,000 | +11.9% | 315,960 | +25.9% | 0.12% | -2.4% |
| Q4 2017 | $2,058,000 | +34.8% | 251,033 | +72.6% | 0.12% | +20.2% |
| Q3 2017 | $1,527,000 | -30.8% | 145,423 | -27.4% | 0.10% | -27.8% |
| Q2 2017 | $2,208,000 | +25.2% | 200,213 | +9.9% | 0.14% | +51.6% |
| Q1 2017 | $1,763,000 | – | 182,157 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 4,133,464 | $45,592,000 | 5.54% |
| Stonepine Capital Management, LLC | 747,863 | $8,249,000 | 4.45% |
| JW Asset Management, LLC | 444,439 | $4,902,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $40,320,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 1,150,000 | $12,685,000 | 1.62% |
| FALCON POINT CAPITAL, LLC | 855,101 | $9,432,000 | 1.27% |
| Perceptive Advisors | 1,429,114 | $15,763,000 | 0.79% |
| KNOTT DAVID M | 126,463 | $1,395,000 | 0.58% |
| HEARTLAND ADVISORS INC | 700,000 | $7,721,000 | 0.50% |
| Sio Capital Management, LLC | 91,413 | $1,008,000 | 0.48% |